Current Value of Holding

$349 Million

Shares

1.06 Million

% of Portfolio

0.36%

Average Buy Price

$341

Avg closing price
Price range

43 Ken Griffin West Pharmaceutical Services Trades

Ken Griffin acquired 1.06 Million West Pharmaceutical Services shares worth $349 Million. That's 0.36% of their equity portfolio (36th largest holding). The investor owns 1.46% of the outstanding West Pharmaceutical Services stock. The first West Pharmaceutical Services trade was made in Q2 2013. Since then Ken Griffin bought shares 49 more times and sold shares on 40 occasions. The investor's estimated purchase price is $361 Million, resulting in a loss of 3.5%.

Avg closing price
Price range
Increased shares by 14.1% (+131 Thousand shares) Q1 2024
Avg closing price $369.91
Price range $338.27 - $413.00
Sold 40.1% shares (-623 Thousand shares) Q4 2023
Avg closing price $353.90
Price range $318.29 - $392.21
Increased shares by 47.3% (+498 Thousand shares) Q3 2023
Avg closing price $386.88
Price range $354.90 - $412.41
Sold 4.2% shares (-45.9 Thousand shares) Q2 2023
Avg closing price $357.24
Price range $334.63 - $382.47
Increased shares by 582.4% (+938 Thousand shares) Q1 2023
Avg closing price $292.19
Price range $232.50 - $346.47
Sold 25.7% shares (-55.8 Thousand shares) Q4 2022
Avg closing price $236.96
Price range $209.34 - $261.61
Increased shares by 60.7% (+82 Thousand shares) Q3 2022
Avg closing price $304.64
Price range $246.08 - $343.65
Sold 65.9% shares (-260 Thousand shares) Q2 2022
Avg closing price $325.39
Price range $280.61 - $420.45
Increased shares by 38790.8% (+394 Thousand shares) Q1 2022
Avg closing price $391.48
Price range $357.49 - $445.92
Sold 98.2% shares (-54.9 Thousand shares) Q4 2021
Avg closing price $430.44
Price range $402.25 - $471.34
Increased shares by 102.1% (+28.3 Thousand shares) Q3 2021
Avg closing price $421.55
Price range $363.01 - $468.47
New holding (+27.7 Thousand shares) Q2 2021
Avg closing price $330.40
Price range $284.77 - $363.20
Sold -5.17 Thousand shares Q1 2021
Avg closing price $286.20
Price range $257.29 - $307.53
Sold 96.3% shares (-136 Thousand shares) Q3 2020
Avg closing price $264.64
Price range $224.99 - $288.02
Increased shares by 1054.4% (+129 Thousand shares) Q2 2020
Avg closing price $196.48
Price range $149.80 - $227.17
Sold 65.4% shares (-23.1 Thousand shares) Q1 2020
Avg closing price $153.92
Price range $128.96 - $174.76
Sold 72.5% shares (-93.2 Thousand shares) Q4 2019
Avg closing price $145.60
Price range $137.60 - $151.21
Increased shares by 107.8% (+66.6 Thousand shares) Q3 2019
Avg closing price $137.68
Price range $121.41 - $150.02
Increased shares by 383.1% (+49 Thousand shares) Q2 2019
Avg closing price $118.04
Price range $111.27 - $125.15
Increased shares by 287.2% (+9.49 Thousand shares) Q1 2019
Avg closing price $104.02
Price range $94.53 - $110.20

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!